C2P Mobilization Intervention (Pilot)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00393575 |
Recruitment Status
:
Completed
First Posted
: October 30, 2006
Last Update Posted
: February 28, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
HIV Infections | Behavioral: Community Mobilization | Not Applicable |
The objective of Phase III is to initiate and complete a community mobilization intervention aimed at ultimately reducing HIV incidence and prevalence among youth. The intervention will consist of guiding C2P coalitions through a strategic planning process that will result in the development and implementation of a local action plan. The action plan will focus on changing structural elements of the affected communities that are believed to be associated with youth HIV acquisition and transmission. Each coalition's plan will include: (1) identification of potential community structural changes and specific steps for how to effect such changes; and (2) the selection of a community-level Centers for Disease Control and Prevention (CDC)-endorsed HIV prevention program. These activities will be described in this document. Details related to the training, technical assistance, adaptation, and implementation of the selected CDC program will be subsequently submitted for IRB review as part two of Phase III (ATN 041).
The intervention consists of community mobilization activities that are expected to lead to structural change and the adaptation and delivery of a CDC-endorsed HIV-prevention program. ATN/C2P staff at each site, with training and technical assistance from a C2P National Coordinating Center, will engage in a strategic planning process with their coalition members that results in the development and implementation of a local action plan.
The evaluation of the intervention will be within and across ATN/C2P sites implementing this protocol. For assessing the overall efficacy of the community mobilization intervention, data will be collected and analyzed from:
- ATN/C2P site staff, in the form of systematic documentation of the community mobilization process and accomplishments (e.g., structural change achieved); and
- Local public health departments and other similar sources of epidemiological information, as was done for generating Phase I epidemiologic profiles.
Duration: 4 years.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 15 participants |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | Connect To Protect® Partnerships for Youth Prevention Interventions: Phase III |
Study Start Date : | January 2006 |
Actual Primary Completion Date : | March 2010 |
Actual Study Completion Date : | March 2010 |

Arm | Intervention/treatment |
---|---|
Experimental: Community Mobilization
The intervention population is defined as the community each site is attempting to mobilize.
|
Behavioral: Community Mobilization
The intervention will consist of guiding C2P coalitions through a strategic planning process that will result in the development and implementation of a local action plan. The action plan will focus on changing structural elements of the affected communities that are believed to be associated with youth HIV acquisition and transmission. Each coalition's plan will include: (1) identification of potential community structural changes and specific steps for how to effect such changes; and (2) the selection of a community-level Centers for Disease Control and Prevention (CDC)-endorsed HIV prevention program.
|
- Increasing levels of community mobilization will be associated with increasing levels of structural change over four years, as measured by new or modified programs, policies, and practices, within and across intervention communities. [ Time Frame: Determined in analysis ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Senior |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Community each ATN/C2P site is attempting to mobilize
Exclusion Criteria:
- Non-ATN funded site

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00393575
United States, California | |
Children's Hospital of Los Angeles | |
Los Angeles, California, United States, 90054 | |
Univ of California at San Diego | |
San Diego, California, United States, 92093-0672 | |
Univ of California at San Francisco | |
San Francisco, California, United States, 94143-0503 | |
United States, District of Columbia | |
Children's Hosp. National Med. Ctr. | |
Washington, District of Columbia, United States, 20010 | |
United States, Florida | |
Children's Diag. & Treatment Ctr. | |
Fort Lauderdale, Florida, United States, 33301 | |
University of Miami | |
Miami, Florida, United States, 33101 | |
University of South Florida | |
Tampa, Florida, United States, 33606 | |
United States, Illinois | |
Stroger Hospital of Cook County | |
Chicago, Illinois, United States, 60612 | |
United States, Louisiana | |
Tulane Medical Center | |
New Orleans, Louisiana, United States, 70112 | |
United States, Maryland | |
University of Maryland | |
Baltimore, Maryland, United States, 21201 | |
United States, Massachusetts | |
Childrens' Hospital Boston | |
Boston, Massachusetts, United States, 02115 | |
United States, New York | |
Director, Adolescent AIDS Program | |
Bronx, New York, United States, 10467-2490 | |
Mount Sinai Medical Center | |
New York, New York, United States, 10128 | |
United States, Pennsylvania | |
The Children's Hosp. of Philadelphia | |
Philadelphia, Pennsylvania, United States, 19104 | |
Puerto Rico | |
University Pediatric Hospital | |
San Juan, Puerto Rico, 00936-5067 |
Study Chair: | Jonathan Ellen, MD | Johns Hopkins University Hospital |
Additional Information:
Responsible Party: | University of North Carolina, Chapel Hill |
ClinicalTrials.gov Identifier: | NCT00393575 History of Changes |
Other Study ID Numbers: |
ATN 040 |
First Posted: | October 30, 2006 Key Record Dates |
Last Update Posted: | February 28, 2017 |
Last Verified: | July 2016 |
Keywords provided by University of North Carolina, Chapel Hill:
HIV Prevention HIV positive communities |
Additional relevant MeSH terms:
HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases |